Elevating Endovascular Surgical Robotics Leader

Challenge:

In the increasingly competitive and noisy surgical robotics sector, Stereotaxis tapped MWW Health to elevate their media presence to the next level and drive broader media interest and discussions that resonate with not only surgeon end-users but a new expanded audience of potential partners, investors, and other decision-makers across the broader healthcare landscape.

Approach:

  • Amplify pipeline of growth milestones to fuel news-driven media relations and anchor timely “why now” hooks for company coverage and trend-oriented stories​
  • Augment PR approach by introducing new ingredients that strengthen story and media appeal including KOL spokesperson bench, real-world case studies, and data-driven proof points​
  • Introduce thought leadership and bigger picture storytelling into media strategy by building key messages to elevate the expert voices behind the momentum and add clinical credibility to brand​
  • Connect the dots between momentum, market trends, macro health crises, global impact significance and meaningful change media / key stakeholders must know ​
  • Educate on value propositions to demonstrate value that goes beyond incremental and presents as transformative for health systems, clinicians, investors, strategics, and patients

Impact:

  • Nearly doubled total earned media coverage secured in 2024, securing 110+ pieces of unique earned editorial coverage
  • Expanded media mix by more than 2X from 14 publications in 2024 to more than 35 outlets in 2025, including high value media such at Modern Healthcare, MedTech Dive, and Forbes
  • Established CEO and KOLs as authority voices in the space with over 35 pieces of thought leadership-focused coverage utilizing new key elements to fuel more robust storytelling beyond corporate news or milestones ​
  • Stereotaxis dubbed “one to watch” by top industry trade outlet, MedTech Dive, and enjoyed significant increase in stock price, positioned as “good buy” by previously skeptical finance analysts ​
As the UK looks to expand surgical robotics, leaders are taking a cue from the US
FDA clearances: Fujifilm Sonosite, Stereotaxis, Adaptix, Alomega
When innovation outpaces adoption, patients pay the price